Cough, Cold, Flu and Allergy Remedies - US - April 2018
Total sales for the cough, cold, flu, and allergy remedy market reached $9.5 billion in 2017, a 6.2% increase from 2016. The start to a record-breaking flu season has already driven an 8.7% increase in the cold and sinus remedies segment, fueled by sales of flagship, multi-functional brands such as Mucinex, Vicks, and Tylenol. The majority of consumers have experienced an ailment within the past 12 months, and seek easy-to-use, accessible, and effective remedies – mainly OTC medications – to treat symptoms. Private label and natural remedies are showing heightened growth, while consumers are prioritizing value and convenience when shopping for ailment remedies.
This report looks at the following areas:
Emphasis on value can limit market growth, constrain profit margins
Some ailment sufferers are not engaged in prompt treatment
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook